COVID-19  Vaccine Immunogenicity and Safety in ImmunoDeficient Patients

Thank you for your interest in the VISID study, enrollment is now closed.

Our project’s aim is to learn more about the effectiveness, safety, and immune response in individuals with low or compromised immune systems who have been vaccinated with the Pfizer-BioNTech or Moderna mRNA or Astrazeneca COVID-19 vaccines.

Our Study